|
|
 |
|
Viewing report
|
|
|
|
Handbook of Drug Screening, Second Edition
Informa Healthcare, June 2009, Pages: 504
Building upon the foundation of basics discussed in the previous edition, the Second Edition provides a more in-depth look at the latest methods and technologies of advanced drug screening, an essential function of drug discovery.
With extensively updated content and 21 new chapters, this text examines:
- quality and efficiency of drug target validation and potential drug compound selection
- reducing assay costs and improvement in assay technology
- data quality improvement
- trends in drug discovery
- how drug screening can minimize adverse drug effects
- recent advancements, including: high content screening; protein-protein interactions; high-throughput crystallization; lead optimization; chemoinformatics and microfluidics technologies; target validation by genomics, proteomics, and siRNA; structure-based drug design; automation; and medicinal chemistry
Customers who bought this item also bought
Cell-Based Assays - Global Strategic Business Report
High Throughput Screening (HTS) - Global Strategic Business Report
Molecular Diagnostics - Technologies, Markets and Companies
Outlook for RNAi, 2007: siRNA and miRNA in Biology, Diagnostics and Therapeutics
ADME-Toxicology Testing - Global Strategic Business Report
Biomarkers - Global Strategic Business Report
Development of Cell-Based Assays (Technical Insights)
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Advances in Laboratory Automation Markets in Europe
Molecular Diagnostics in Cancer Testing
|
|
|
|
